Total Funding
61
55
Total FundingGrant raised
Growth Score
-18 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
63768
Cardiawave is a medical device company .
- Fabienne Betting: Chief Technology Officer
- Benjamin Bertrand: Co-Founder & Board MemberPast Role: Eukarys, Board member (Co-founder and CEO)
About the Company
Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging.
Led by an experienced management
team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.
